title: Late-onset facial abscess formation after cosmetic soft tissue augmentation with bio-alcamid.
abstract: Bio-Alcamid (BA) (polyalkylimide) was introduced in Europe in 2001. It is a nonresorbable injectable filler for soft tissue augmentation, indicated for a wide variety of clinical applications in reconstructive and cosmetic surgery in conditions where subcutaneous volumetric compensation is required. Although BA biocompatibility was approved by a European Union Certificate (CE), the substance is not a natural component of biologic tissues, and thus inflammation and infection are still potential risks. The authors present a case of BA infection after minor trauma 3 years after bilateral injections to the malar regions in a 43-year-old woman, causing an abscess that required surgical drainage and parenteral antibiotics.
authors.affiliation: Department of Plastic and Reconstructive Surgery, The Chaim Sheba Medical Center, Israel.
authors.forename: Oren
authors.initials: O
authors.lastname: Goldan
authors.forename: Ioannis
authors.initials: I
authors.lastname: Georgiou
authors.forename: Nimrod
authors.initials: N
authors.lastname: Farber
authors.forename: Eyal
authors.initials: E
authors.lastname: Winkler
authors.forename: Josef
authors.initials: J
authors.lastname: Haik
authors.forename: Arie
authors.initials: A
authors.lastname: Orenstein